COVID-19 vaccines: Immune correlates and clinical outcomes

COVID-19 vaccines: Immune correlates and clinical outcomes

ABSTRACTSevere disease due to COVID-19 has declined dramatically as a result of widespread vaccination and natural immunity in the population. With the emergence of SARS-CoV-2 variants that largely escape vaccine-elicited neutralizing antibody responses, the efficacy of the original vaccines has wan...

Full description

Bibliographic Details
Main Authors:	Shant H. Mahrokhian, Lisa H. Tostanoski, Samuel J. Vidal, Dan H. Barouch
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	COVID-19 immune correlates vaccines SARS-CoV-2 variants mucosal immunity T-cells
Online Access:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2324549

Similar Items

An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response
by: Li Chen, et al.
Published: (2022-11-01)

COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
by: Wei-Yu Chi, et al.
Published: (2022-10-01)

Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection
by: Minami Nagai, et al.
Published: (2021-08-01)

SARS-CoV-2–specific mucosal immune response in vaccinated versus infected children
by: Maria Giulia Conti, et al.
Published: (2024-03-01)

Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection
by: Emilie Goguet, et al.
Published: (2024-03-01)

Nature of Acquired Immune Responses, Epitope Specificity and Resultant Protection from SARS-CoV-2
by: Reginald M. Gorczynski, et al.
Published: (2021-11-01)

Humoral Response Kinetics and Cross-Immunity in Hospitalized Patients with SARS-CoV-2 WT, Delta, or Omicron Infections: A Comparison between Vaccinated and Unvaccinated Cohorts
by: Hyunhye Kang, et al.
Published: (2023-12-01)

A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
by: Ali A. Rabaan, et al.
Published: (2022-10-01)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
by: Priyal Mistry, et al.
Published: (2022-01-01)

Systemic Neutralizing Antibodies and Local Immune Responses Are Critical for the Control of SARS-CoV-2
by: Shaswath S. Chandrasekar, et al.
Published: (2022-06-01)

A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates
by: Sarah N. Tedjakusuma, et al.
Published: (2024-01-01)

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
by: Ahmed O. Hassan, et al.
Published: (2021-07-01)

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
by: Ahlam Chaqroun, et al.
Published: (2021-06-01)

An RNA-Scaffold Protein Subunit Vaccine for Nasal Immunization
by: Joy-Yan Lam, et al.
Published: (2023-09-01)

Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice
by: Raj S. Patel, et al.
Published: (2023-06-01)

Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients
by: Bernadette Crescenzo-Chaigne, et al.
Published: (2021-12-01)

Development of an Oral IgA Response against SARS-CoV-2 Following Immunization with Different COVID-19 Vaccines
by: Irene Soffritti, et al.
Published: (2023-11-01)

Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants
by: Cai He, et al.
Published: (2023-03-01)

A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
by: Ahmed O. Hassan, et al.
Published: (2021-04-01)

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters
by: Benjamin Vesin, et al.
Published: (2022-12-01)

Vaccine Strategies to Elicit Mucosal Immunity
by: Yufeng Song, et al.
Published: (2024-02-01)

Reduced maternal immunity and vertical transfer of immunity against SARS-CoV-2 variants of concern with COVID-19 exposure or initial vaccination in pregnancy
by: Rupsa C. Boelig, et al.
Published: (2023-09-01)

Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study
by: Giovanni Corrao, et al.
Published: (2022-02-01)

Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease
by: Sedigheh Taghinezhad-S, et al.
Published: (2021-05-01)

Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
by: Floriane Gallais, et al.
Published: (2022-02-01)

The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines
by: Yao Jiang, et al.
Published: (2022-01-01)

Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns
by: Paola Zelini, et al.
Published: (2023-04-01)

<italic toggle="yes">Lactobacillus</italic> Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens
by: Jonathan S. LeCureux, et al.
Published: (2018-06-01)

The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
by: Zhongjie Sun, et al.
Published: (2022-07-01)

Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination
by: Brittany A. Comunale, et al.
Published: (2024-02-01)

The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs
by: Wenqiang Sun, et al.
Published: (2022-06-01)

Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
by: Yandi Zhang, et al.
Published: (2021-11-01)

Evaluation of the humoral and mucosal immune response of a multiepitope vaccine against COVID-19 in pigs
by: Juan Mosqueda, et al.
Published: (2023-12-01)

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
by: Kuldeep Dhama, et al.
Published: (2022-11-01)

Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
by: Tulio J. Lopera, et al.
Published: (2022-05-01)

A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety
by: Md. Aminul Islam
Published: (2023-12-01)

A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine
by: Jingen Zhu, et al.
Published: (2022-08-01)

Rapid increase in salivary IgA and broad recognition of spike protein following SARS-CoV-2 vaccination
by: Kenji Ota, et al.
Published: (2024-01-01)

A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
by: Xiantao Zhang, et al.
Published: (2023-09-01)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
by: Fuxing Lou, et al.
Published: (2021-11-01)